14 products were found matching your search for EpithelialMesenchymal Interactions in Cancer in 1 shops:

Cancer Pharmacology and Pharmacotherapy Reviewis the first book devoted entirely to providing the "must-know" facts on each cancer agent, including their pharmacokinetics, FDA-approved indications,toxicity, interactions, and other important information that is commonly found on board examinations and essential for any clinician or practitioner to review. The authors, an oncologist and two pharmacists, have developed a handy question-and-answer format to present the material in digestible bursts. As the pharmacology section continues to represent a major portion of the medical oncology exam and a key component on oncology MOC exams, this portable study guide will help prepare anyone looking to fine-tune their knowledge on cancer drugs before the test. Not to mention, with recent advancements in the field of cancer treatment, it has become more cumbersome to recall and maintain essential knowledge of every cancer therapeutic, making this book not only an exam resource but also a handy quick reference for oncologists and pharmacists alike. KEY FEATURES Conveniently organized and arranged by drug class and subtypes for easier recall and classification Includes proper dosage adjustments to account for liver and kidney dysfunction Features tables throughout that provide quick reference regarding FDA-approved medications Simplified diagrams and illustrations facilitate the pharmacokinetic processes

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

Initiation of cancer in the cell is experimentally related to action of chemicals and radiation. For understanding the first steps of this interaction, approved methods from quantum theory and solid state physics are applied by the authors.The approach of this book is interdisciplinary. Theoretical models are qualitatively applied. Known effects, like oncogene activation, anti-oncogenes, and disturbances of the cell's self-regulation are explained. The authors propose possible points of intervention in the cancer initiation process based on the theoretical considerations.

Cancer Pharmacology and Pharmacotherapy Reviewis the first book devoted entirely to providing the "must-know" facts on each cancer agent, including their pharmacokinetics, FDA-approved indications,toxicity, interactions, and other important information that is commonly found on board examinations and essential for any clinician or practitioner to review. The authors, an oncologist and two pharmacists, have developed a handy question-and-answer format to present the material in digestible bursts. As the pharmacology section continues to represent a major portion of the medical oncology exam and a key component on oncology MOC exams, this portable study guide will help prepare anyone looking to fine-tune their knowledge on cancer drugs before the test. Not to mention, with recent advancements in the field of cancer treatment, it has become more cumbersome to recall and maintain essential knowledge of every cancer therapeutic, making this book not only an exam resource but also a handy quick reference for oncologists and pharmacists alike. KEY FEATURES Conveniently organized and arranged by drug class and subtypes for easier recall and classification Includes proper dosage adjustments to account for liver and kidney dysfunction Features tables throughout that provide quick reference regarding FDA-approved medications Simplified diagrams and illustrations facilitate the pharmacokinetic processes

The study of interactions between genes and environmental exposures has expanded considerably in recent years. Highly penetrant genes that are involved in familial cancer have been identified, but are likely to account for a relatively small proportion of total cancers. Other predisposinggenes have low penetrance, resulting in a moderate increase in the risk of specific cancers, but are widespread in the general population. This is the case for so-called metabolic polymorphisms. Scientific interest in metabolic polymorphisms is based on the possibility of identifying subgroups ofthe population which are at elevated risk of developing environmentally-induced cancer. However, such studies raise a series of problems that are methodological - related to the study design and analysis - and ethical - related to the practical use that can be made of genetic information. Thisvolume deals thoroughly with such problems.

Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Describes in detail interactions between cancerous cells and various components of the innate and adaptive immune systemFocuses on clinical aspects in order to educate clinicians in the clinical implications of recent research and new developments.

Air pollution, water contamination, persistent organic pollutants, pesticides, metals, and radiofrequencies are just some examples of environmental factors that have been linked to adverse health effects such as cancer, respiratory disease and reproductive problems. Environmental epidemiology studies the interaction of disease and these environmental determinants of disease at a population level. Whilst risks associated with environmental exposures are generally small, the exposed population, and hence the population burden of disease, may be large. To detect these small risks, it is therefore essential that related methods and their application are refined. In addition, there is increasing attention on environmental health issues from the public, government, and media, thus raising the profile of envrionmental epidemiology in preventive medicine. This book describes the methods of environmental epidemiology, with emphasis on good practice. It outlines the basic principles of epidemiology and environmental health, and describes in more detail special environmental epidemiological designs that are rarely described in other textbooks. The principles of health risk assessment and forecasting, as well as the application of study data in these types of study, are explored. Several chapters cover practical issues in the conduct of studies, such as field work and data analyses and its requirements. Ethical issues and the role of environmental epidemiology in policy making are also covered.

...a classic text, covers both the basic and clinical aspects of the entire sub-specialty...discusses new findings on cellular mechanisms, bone/mineral interactions, and management of thyroid cancer.

Air pollution, water contamination, persistent organic pollutants, pesticides, metals, and radiofrequencies are just some examples of environmental factors that have been linked to adverse health effects such as cancer, respiratory disease and reproductive problems. Environmental epidemiology studies the interaction of disease and these environmental determinants of disease at a population level. Whilst risks associated with environmental exposures are generally small, the exposed population, and hence the population burden of disease, may be large. To detect these small risks, it is therefore essential that related methods and their application are refined. In addition, there is increasing attention on environmental health issues from the public, government, and media, thus raising the profile of envrionmental epidemiology in preventive medicine. This book describes the methods of environmental epidemiology, with emphasis on good practice. It outlines the basic principles of epidemiology and environmental health, and describes in more detail special environmental epidemiological designs that are rarely described in other textbooks. The principles of health risk assessment and forecasting, as well as the application of study data in these types of study, are explored. Several chapters cover practical issues in the conduct of studies, such as field work and data analyses and its requirements. Ethical issues and the role of environmental epidemiology in policy making are also covered.

The reemergence of infectious bacterial diseases resistant to multiple antibiotics, the rise to epidemic levels of infectious diseases such as AIDS, and the increasing incidence of fatal diseases such as cancer and tuberculosis are indicative of a failure of modern medicine to understand the complex interaction of disease, human evolution, and modern therapeutics. Evolutionary Medicine: Rethinking the Origins of Disease is an exploration of the origins of the new patterns of such diseases and the forces that shape their evolution.Marc Lappe provides a new perspective on illness and disease, one which presents diseases as evolutionary processes linked inextricably with environmental and ecological factors. Since all human illnesses have their roots in the forces that shaped evolution, it is critical to realize that human-made disruptions to the environment are now shaping the patterns of disease around the world as are the treatments that are being utilized to combat them.Lappe argues that neglecting the evolutionary approaches to diseases has undermined the long-term success of modern medicine. Understanding the ways in which diseases have evolved, as well as what mechanisms have evolved to cope with them, is invaluable to those who are attempting to advise strategies for treatment.By identifying a new perspective from which to view our present medical dilemmas, and by exploring the common roots of such events as the proliferation of HIV, the emergence of antibiotic-resistant bacteria, and key autoimmune diseases, Marc Lappe has provided the basis for a new field, that of evolutionary medicine.

In a family study of breast cancer, epidemiologists in Southern California increase the power for detecting a gene-environment interaction. In Gambia, a study helps a vaccination program reduce the incidence of Hepatitis B carriage. Archaeologists in Austria place a Bronze Age site in its true temporal location on the calendar scale. And in France, researchers map a rare disease with relatively little variation.Each of these studies applied Markov chain Monte Carlo methods to produce more accurate and inclusive results. General state-space Markov chain theory has seen several developments that have made it both more accessible and more powerful to the general statistician. Markov Chain Monte Carlo in Practice introduces MCMC methods and their applications, providing some theoretical background as well. The authors are researchers who have made key contributions in the recent development of MCMC methodology and its application. Considering the broad audience, the editors emphasize practice rather than theory, keeping the technical content to a minimum. The examples range from the simplest application, Gibbs sampling, to more complex applications. The first chapter contains enough information to allow the reader to start applying MCMC in a basic way. The following chapters cover main issues, important concepts and results, techniques for implementing MCMC, improving its performance, assessing model adequacy, choosing between models, and applications and their domains.Markov Chain Monte Carlo in Practice is a thorough, clear introduction to the methodology and applications of this simple idea with enormous potential. It shows the importance of MCMC in real applications, such as archaeology, astronomy, biostatistics, genetics, epidemiology, and image analysis, and provides an excellent base for MCMC to be applied to other fields as well.

In a family study of breast cancer, epidemiologists in Southern California increase the power for detecting a gene-environment interaction. In Gambia, a study helps a vaccination program reduce the incidence of Hepatitis B carriage. Archaeologists in Austria place a Bronze Age site in its true temporal location on the calendar scale. And in France, researchers map a rare disease with relatively little variation.Each of these studies applied Markov chain Monte Carlo methods to produce more accurate and inclusive results. General state-space Markov chain theory has seen several developments that have made it both more accessible and more powerful to the general statistician. Markov Chain Monte Carlo in Practice introduces MCMC methods and their applications, providing some theoretical background as well. The authors are researchers who have made key contributions in the recent development of MCMC methodology and its application. Considering the broad audience, the editors emphasize practice rather than theory, keeping the technical content to a minimum. The examples range from the simplest application, Gibbs sampling, to more complex applications. The first chapter contains enough information to allow the reader to start applying MCMC in a basic way. The following chapters cover main issues, important concepts and results, techniques for implementing MCMC, improving its performance, assessing model adequacy, choosing between models, and applications and their domains.Markov Chain Monte Carlo in Practice is a thorough, clear introduction to the methodology and applications of this simple idea with enormous potential. It shows the importance of MCMC in real applications, such as archaeology, astronomy, biostatistics, genetics, epidemiology, and image analysis, and provides an excellent base for MCMC to be applied to other fields as well.

...a classic text, covers both the basic and clinical aspects of the entire sub-specialty...discusses new findings on cellular mechanisms, bone/mineral interactions, and management of thyroid cancer.